Main Article Content
Interleukin-10 (IL-10) induction of uteroglobulin-related protein 1 (UGRP1) gene expression was examined using human lung adenocarcinoma NCI-H441 cells. Treatment of the
Cells with 25 or 50 ng/ml IL-10 induced the expression of hUGRP1 mRNA as early as 2 hours and the level of expression continued for at least 24 hours. Actinomycin D inhibited IL-10 induction of hUGRP1 mRNA expression whereas cycloheximide did not have any effect, suggesting that IL-10 regulated hUGRP 1 expression at transcriptional level. Transient transfection analysis with and without IL-10 treatment using several reporter constructs containing up to 324 bp of the hUGRP1 gene promoter sequence revealed a potential transcriptional control site for IL-10 signal transduction between - 179 and - 209 bp of the hUGRP 1 gene promoter. Co-transfection analysis using mutant constructs, gel shift analysis and chromatin immunoprecipitation assay demonstrated that the binding of T/EBP to its specific binding sites at both-187 and -68 bp in the hUGRP1 gene promoter was responsible for IL-10 induction of hUGRP1 gene expression. Both IL-10R subunits, IL-10R1 and IL-10R2, were expressed in NCI-H441 cells; however, STAT3 was barely activated upon IL-10 treatment as judged by Western blotting for phospho-STAT3. When cells were treated with other members of the IL-10 family such as IL-22 and IFN-β, intense band for phospho-STAT3 was obtained while no UGRP1 expression was found. Mouse embryo lungs cultured in the presence of IL-10 and lungs obtained from mice intranasally instilled IL-10 exhibited the increase of Ugrp1 mRNA levels. These results demonstrated that IL-10 induced UGRP1 gene expression in lung epithelial cells through T/EBP-dependent pathway. Together, these findings suggest that UGRP1may play a role in airway anti-inflammatory processes by serving as a downstream transcriptional target of IL-10 activation.
Upon acceptance of an article, the Pharmacological and Therapeutic Society of Thailand will have exclusive right to publish and distribute the article in all forms and media and grant rights to others. Authors have rights to use and share their own published articles.